• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒的基因组流行病学揭示,B.1、B.1.36和B.1.1.7是巴基斯坦第一波、第二波和第三波新冠病毒感染中最主要的谱系。

Genomic Epidemiology of SARS-CoV-2 Divulge B.1, B.1.36, and B.1.1.7 as the Most Dominant Lineages in First, Second, and Third Wave of SARS-CoV-2 Infections in Pakistan.

作者信息

Basheer Atia, Zahoor Imran

机构信息

Genetics and Genomic Laboratory, Department of Animal Breeding and Genetics, University of Veterinary and Animal Sciences, Ravi Campus, Pattoki 55300, Pakistan.

出版信息

Microorganisms. 2021 Dec 17;9(12):2609. doi: 10.3390/microorganisms9122609.

DOI:10.3390/microorganisms9122609
PMID:34946210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8708969/
Abstract

The present study aims to investigate the genomic variability and epidemiology of SARS-CoV-2 in Pakistan along with its role in the spread and severity of infection during the three waves of COVID-19. A total of 453 genomic sequences of Pakistani SARS-CoV-2 were retrieved from GISAID and subjected to MAFFT-based alignment and QC check which resulted in removal of 53 samples. The remaining 400 samples were subjected to Pangolin-based genomic lineage identification. And to infer our SARS-CoV-2 time-scaled and divergence phylogenetic trees, 3804 selected global reference sequences plus 400 Pakistani samples were used for the Nextstrain analysis with Wuhan/Hu-1/2019, as reference genome. Finally, maximum likelihood based phylogenetic tree was built by using the Nextstrain and coverage map was created by employing Nextclade. By using the amino acid substitutions, the maximum likelihood phylogenetic trees were developed for each wave, separately. Our results reveal the circulation of 29 lineages, belonging to following seven clades G, GH, GR, GRY, L, O, and S in the three waves. From first wave, 16 genomic lineages of SARS-CoV-2 were identified with B.1(24.7%), B.1.36(18.8%), and B.1.471(18.8%) as the most prevalent lineages respectively. The second wave data showed 18 lineages, 10 of which were overlapping with the first wave suggesting that those variants could not be contained during the first wave. In this wave, a new lineage, AE.4, was reported from Pakistan for the very first time in the world. However, B.1.36 (17.8%), B.1.36.31 (11.9%), B.1.1.7 (8.5%), and B.1.1.1 (5.9%) were the major lineages in second wave. Third wave data showed the presence of nine lineages with Alpha/B.1.1.7 (72.7%), Beta/B.1.351 (12.99%), and Delta/B.1.617.2 (10.39%) as the most predominant variants. It is suggested that these VOCs should be contained at the earliest in order to prevent any devastating outbreak of SARS-CoV-2 in the country.

摘要

本研究旨在调查巴基斯坦严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的基因组变异性和流行病学,以及其在2019冠状病毒病(COVID-19)三波疫情期间在感染传播和严重程度方面所起的作用。从全球共享流感数据倡议组织(GISAID)检索了总共453条巴基斯坦SARS-CoV-2基因组序列,并进行基于MAFFT的比对和质量控制检查,结果剔除了53个样本。其余400个样本进行基于穿山甲(Pangolin)的基因组谱系鉴定。为了推断我们的SARS-CoV-2时间尺度和分歧系统发育树,将3804条选定的全球参考序列加上400个巴基斯坦样本用于以武汉/胡-1/2019作为参考基因组的Nextstrain分析。最后,使用Nextstrain构建基于最大似然法的系统发育树,并使用Nextclade创建覆盖图。通过氨基酸替换,分别为每一波构建基于最大似然法的系统发育树。我们的结果显示,在三波疫情中共有29个谱系传播,分属于以下七个进化枝:G、GH、GR、GRY、L、O和S。在第一波疫情中,鉴定出16个SARS-CoV-2基因组谱系,其中B.1(24.7%)、B.1.36(18.8%)和B.1.471(18.8%)为最主要的谱系。第二波疫情数据显示有18个谱系,其中10个与第一波重叠,这表明这些变异株在第一波疫情期间未能得到控制。在这一波疫情中,一个新的谱系AE.4首次在世界范围内从巴基斯坦被报道。然而,B.1.36(17.8%)、B.1.36.31(11.9%)、B.1.1.7(8.5%)和B.1.1.1(5.9%)是第二波疫情中的主要谱系。第三波疫情数据显示有9个谱系,其中Alpha/B.1.1.7(72.7%)、Beta/B.1.351(12.99%)和Delta/B.1.617.2(10.39%)为最主要的变异株。建议尽早控制这些变异株,以防止该国出现任何毁灭性的SARS-CoV-2疫情爆发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/b84b6b31d410/microorganisms-09-02609-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/0ae06b564543/microorganisms-09-02609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/0c0349afb026/microorganisms-09-02609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/aeeee7239514/microorganisms-09-02609-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/f6d55b5df37e/microorganisms-09-02609-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/709f00a6ca9c/microorganisms-09-02609-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/601a3e267334/microorganisms-09-02609-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/89e8836d5615/microorganisms-09-02609-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/c72a1bf24d66/microorganisms-09-02609-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/7c5100832f0e/microorganisms-09-02609-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/867058f1f121/microorganisms-09-02609-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/4d7aa1df9a23/microorganisms-09-02609-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/b84b6b31d410/microorganisms-09-02609-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/0ae06b564543/microorganisms-09-02609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/0c0349afb026/microorganisms-09-02609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/aeeee7239514/microorganisms-09-02609-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/f6d55b5df37e/microorganisms-09-02609-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/709f00a6ca9c/microorganisms-09-02609-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/601a3e267334/microorganisms-09-02609-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/89e8836d5615/microorganisms-09-02609-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/c72a1bf24d66/microorganisms-09-02609-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/7c5100832f0e/microorganisms-09-02609-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/867058f1f121/microorganisms-09-02609-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/4d7aa1df9a23/microorganisms-09-02609-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6264/8708969/b84b6b31d410/microorganisms-09-02609-g012.jpg

相似文献

1
Genomic Epidemiology of SARS-CoV-2 Divulge B.1, B.1.36, and B.1.1.7 as the Most Dominant Lineages in First, Second, and Third Wave of SARS-CoV-2 Infections in Pakistan.新冠病毒的基因组流行病学揭示,B.1、B.1.36和B.1.1.7是巴基斯坦第一波、第二波和第三波新冠病毒感染中最主要的谱系。
Microorganisms. 2021 Dec 17;9(12):2609. doi: 10.3390/microorganisms9122609.
2
Complete Genomic Characterisation and Mutation Patterns of Iraqi SARS-CoV-2 Isolates.伊拉克新冠病毒分离株的全基因组特征及突变模式
Diagnostics (Basel). 2022 Dec 21;13(1):8. doi: 10.3390/diagnostics13010008.
3
Timeline of SARS-CoV-2 Transmission in Sabah, Malaysia: Tracking the Molecular Evolution.马来西亚沙巴州新冠病毒传播时间线:追踪分子进化
Pathogens. 2023 Aug 15;12(8):1047. doi: 10.3390/pathogens12081047.
4
Characterization and phylogenetic analysis of Iranian SARS-CoV-2 genomes: A phylogenomic study.伊朗严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组的特征分析与系统发育分析:一项系统基因组学研究
Health Sci Rep. 2023 Jan 16;6(1):e1052. doi: 10.1002/hsr2.1052. eCollection 2023 Jan.
5
Temporal dynamics and fatality of SARS-CoV-2 variants in Bangladesh.孟加拉国新冠病毒变异株的时间动态和致死率
Health Sci Rep. 2023 Apr 17;6(4):e1209. doi: 10.1002/hsr2.1209. eCollection 2023 Apr.
6
Phylogenetic classification of the whole-genome sequences of SARS-CoV-2 from India & evolutionary trends.印度地区 SARS-CoV-2 全基因组序列的系统发育分类及进化趋势。
Indian J Med Res. 2021;153(1 & 2):166-174. doi: 10.4103/ijmr.IJMR_3418_20.
7
Molecular Analysis of SARS-CoV-2 Circulating in Bangladesh during 2020 Revealed Lineage Diversity and Potential Mutations.2020年孟加拉国流行的新型冠状病毒2019(SARS-CoV-2)的分子分析揭示了谱系多样性和潜在突变。
Microorganisms. 2021 May 12;9(5):1035. doi: 10.3390/microorganisms9051035.
8
Genomic Diversity and Evolution of SARS-CoV-2 Lineages in Pakistan.巴基斯坦 SARS-CoV-2 谱系的基因组多样性与进化。
Viruses. 2023 Jun 27;15(7):1450. doi: 10.3390/v15071450.
9
Spatiotemporal genome diversity of SARS-CoV-2 in wastewater: a two-year global epidemiological study.污水中 SARS-CoV-2 的时空基因组多样性:一项为期两年的全球流行病学研究。
Environ Monit Assess. 2023 Dec 16;196(1):44. doi: 10.1007/s10661-023-12228-z.
10
Screening and Whole Genome Sequencing of SARS-CoV-2 Circulating During the First Three Waves of the COVID-19 Pandemic in Libreville and the Haut-Ogooué Province in Gabon.在加蓬利伯维尔和上奥果韦省新冠疫情前三波期间流行的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的筛查与全基因组测序
Front Med (Lausanne). 2022 May 17;9:877391. doi: 10.3389/fmed.2022.877391. eCollection 2022.

引用本文的文献

1
Nanopore sequencing reveals the genomic diversity of the variants of concern of SARS-CoV-2 during 2021 disease outbreak in Pakistan.纳米孔测序揭示了2021年巴基斯坦疾病爆发期间新冠病毒变异株的基因组多样性。
Sci Rep. 2025 Aug 1;15(1):28129. doi: 10.1038/s41598-025-12774-1.
2
The introduction of the SARS-CoV-2 BA.4 lineage into Pakistan.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)BA.4谱系毒株传入巴基斯坦。
Arch Virol. 2025 Jan 6;170(2):26. doi: 10.1007/s00705-024-06211-3.
3
Genetic diversity and genomic epidemiology of SARS-CoV-2 during the first 3 years of the pandemic in Morocco: comprehensive sequence analysis, including the unique lineage B.1.528 in Morocco.

本文引用的文献

1
The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the B.1.1.7 lineage (VOC α) in some French regions in April 2021.2021 年 4 月,在法国的一些地区,SARS-CoV-2 的 B.1.351 谱系(VOC β)的增长率超过了 B.1.1.7 谱系(VOC α)。
Euro Surveill. 2021 Jun;26(23). doi: 10.2807/1560-7917.ES.2021.26.23.2100447.
2
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.一种刺突蛋白L452R新冠病毒变异株的传播、传染性和中和作用
Cell. 2021 Jun 24;184(13):3426-3437.e8. doi: 10.1016/j.cell.2021.04.025. Epub 2021 Apr 20.
3
An Overview of the Treatment Options Used for the Management of COVID-19 in Pakistan: Retrospective Observational Study.
摩洛哥疫情头三年期间严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的遗传多样性和基因组流行病学:全面序列分析,包括摩洛哥独特的B.1.528谱系
Access Microbiol. 2024 Oct 7;6(10). doi: 10.1099/acmi.0.000853.v4. eCollection 2024.
4
Impact of COVID-19 vaccination: a global perspective.2019冠状病毒病疫苗接种的影响:全球视角
Front Public Health. 2024 Jan 11;11:1272961. doi: 10.3389/fpubh.2023.1272961. eCollection 2023.
5
COVID-19 in Pakistan: A national analysis of five pandemic waves.巴基斯坦的 COVID-19 疫情:五次大流行浪潮的国家分析。
PLoS One. 2023 Dec 29;18(12):e0281326. doi: 10.1371/journal.pone.0281326. eCollection 2023.
6
Impact of Comorbidity on the Duration from Symptom Onset to Death in Patients with Coronavirus Disease 2019: A Retrospective Study of 104,753 Cases in Pakistan.合并症对2019冠状病毒病患者从症状出现到死亡持续时间的影响:巴基斯坦104753例病例的回顾性研究
Diseases. 2023 Dec 1;11(4):176. doi: 10.3390/diseases11040176.
7
Genomic Diversity and Evolution of SARS-CoV-2 Lineages in Pakistan.巴基斯坦 SARS-CoV-2 谱系的基因组多样性与进化。
Viruses. 2023 Jun 27;15(7):1450. doi: 10.3390/v15071450.
8
COVID-19 Vaccines Status, Acceptance and Hesitancy among Maintenance Hemodialysis Patients: A Cross-Sectional Study and the Implications for Pakistan and Beyond.维持性血液透析患者中新冠疫苗的接种状况、接受度及犹豫情况:一项横断面研究及其对巴基斯坦及其他地区的启示
Vaccines (Basel). 2023 Apr 27;11(5):904. doi: 10.3390/vaccines11050904.
9
Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2.基因组结构和进化关系的 BA.2.75:奥密克戎 SARS-CoV-2 的半人马座亚变种。
PLoS One. 2023 May 24;18(5):e0281159. doi: 10.1371/journal.pone.0281159. eCollection 2023.
10
Molecular Characterization and Selection of Indigenous SARS-CoV-2 Delta Variant for the Development of the First Inactivated SARS-CoV-2 Vaccine of Pakistan.用于开发巴基斯坦首款新冠病毒灭活疫苗的本土新冠病毒德尔塔变异株的分子特征分析与筛选
Vaccines (Basel). 2023 Mar 7;11(3):607. doi: 10.3390/vaccines11030607.
《巴基斯坦 COVID-19 管理中使用的治疗方法概述:回顾性观察研究》
JMIR Public Health Surveill. 2021 May 27;7(5):e28594. doi: 10.2196/28594.
4
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.英国伦敦出现的 SARS-CoV-2 B.1.1.7 谱系的基因组特征和临床效果:全基因组测序和基于医院的队列研究。
Lancet Infect Dis. 2021 Sep;21(9):1246-1256. doi: 10.1016/S1473-3099(21)00170-5. Epub 2021 Apr 12.
5
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.巴西玛瑙斯市 P.1 型 SARS-CoV-2 谱系的基因组学和流行病学研究。
Science. 2021 May 21;372(6544):815-821. doi: 10.1126/science.abh2644. Epub 2021 Apr 14.
6
Antibody evasion by the P.1 strain of SARS-CoV-2.SARS-CoV-2 P.1 株的抗体逃逸。
Cell. 2021 May 27;184(11):2939-2954.e9. doi: 10.1016/j.cell.2021.03.055. Epub 2021 Mar 30.
7
SARS-CoV-2 outbreak in Iran: The dynamics of the epidemic and evidence on two independent introductions.伊朗的 SARS-CoV-2 疫情爆发:疫情的动态和两个独立传入的证据。
Transbound Emerg Dis. 2022 May;69(3):1375-1386. doi: 10.1111/tbed.14104. Epub 2021 May 22.
8
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.新冠病毒变异株B.1.429和B.1.351的中和作用
N Engl J Med. 2021 Jun 17;384(24):2352-2354. doi: 10.1056/NEJMc2103740. Epub 2021 Apr 7.
9
Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level.约旦新冠病毒2型(SARS-CoV-2)遗传谱系的分子分析:在国家层面追踪新冠病毒英国变异株(值得关注的变异株)的引入与传播。
Pathogens. 2021 Mar 5;10(3):302. doi: 10.3390/pathogens10030302.
10
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.评估 SARS-CoV-2 谱系 B.1.1.7 在英国的传播能力。
Nature. 2021 May;593(7858):266-269. doi: 10.1038/s41586-021-03470-x. Epub 2021 Mar 25.